Aaron Muth

3.4k total citations · 2 hit papers
55 papers, 2.6k citations indexed

About

Aaron Muth is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Aaron Muth has authored 55 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 11 papers in Oncology. Recurrent topics in Aaron Muth's work include Ubiquitin and proteasome pathways (8 papers), Inhalation and Respiratory Drug Delivery (8 papers) and Nanoparticle-Based Drug Delivery (6 papers). Aaron Muth is often cited by papers focused on Ubiquitin and proteasome pathways (8 papers), Inhalation and Respiratory Drug Delivery (8 papers) and Nanoparticle-Based Drug Delivery (6 papers). Aaron Muth collaborates with scholars based in United States, Egypt and Germany. Aaron Muth's co-authors include Vivek Gupta, Vineela Parvathaneni, Nishant S. Kulkarni, Paul R. Thompson, Snehal K. Shukla, Santanu Mondal, Alf Herzig, Horst von Bernuth, Renate Krüger and Volker Brinkmann and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Aaron Muth

53 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diverse stimuli engage different neutrophil extracellular trap pathways

2017 596 citations Aaron Muth, Paul R. Thompson et al. profile →
Drug repurposing: a promising tool to accelerate the drug discovery process

2019 358 citations Vineela Parvathaneni, Nishant S. Kulkarni et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aaron Muth United States	25	1.1k	798	429	288	279	55	2.6k
Ommoleila Molavi Iran	27	1.3k 1.1×	557 0.7×	209 0.5×	507 1.8×	541 1.9×	73	2.7k
Bastiaan Nuijen Netherlands	30	1.0k 0.9×	340 0.4×	269 0.6×	829 2.9×	396 1.4×	122	2.7k
Bikul Das United States	23	1.6k 1.4×	378 0.5×	332 0.8×	922 3.2×	259 0.9×	54	3.3k
Julie L. Eiseman United States	34	2.1k 1.9×	302 0.4×	263 0.6×	733 2.5×	344 1.2×	131	3.5k
Wenmin Yuan United States	28	896 0.8×	517 0.6×	73 0.2×	366 1.3×	636 2.3×	53	2.2k
Seetharama D. Jois United States	29	1.2k 1.1×	199 0.2×	142 0.3×	326 1.1×	206 0.7×	86	2.0k
Sushil K. Kashaw India	29	1.6k 1.4×	676 0.8×	271 0.6×	1.2k 4.0×	534 1.9×	131	4.7k
Gerd Bendas Germany	32	1.8k 1.6×	329 0.4×	216 0.5×	703 2.4×	440 1.6×	118	3.3k
Anant Narayan Bhatt India	23	1.1k 1.0×	374 0.5×	243 0.6×	612 2.1×	396 1.4×	67	2.7k

Countries citing papers authored by Aaron Muth

Since Specialization

Citations

This map shows the geographic impact of Aaron Muth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron Muth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron Muth more than expected).

Fields of papers citing papers by Aaron Muth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron Muth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron Muth. The network helps show where Aaron Muth may publish in the future.

Co-authorship network of co-authors of Aaron Muth

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron Muth. A scholar is included among the top collaborators of Aaron Muth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron Muth. Aaron Muth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Xuechun, et al.. (2025). Transferrin-conjugated polymeric nanoparticles for receptor-mediated delivery of resveratrol-cyclodextrin complex in non-small cell lung cancer (NSCLC) cells. Journal of Drug Delivery Science and Technology. 105. 106588–106588. 4 indexed citations

Kanabar, Dipti, et al.. (2024). Structural modification of the propyl linker of cjoc42 in combination with sulfonate ester and triazole replacements for enhanced gankyrin binding and anti-proliferative activity. Bioorganic & Medicinal Chemistry. 110. 117836–117836.

Hegazy, Rehab, et al.. (2024). Lenvatinib-valproic acid self nanoemulsifying preconcentrate for the treatment of liver cancer. Journal of Molecular Liquids. 398. 124263–124263. 1 indexed citations

Kanabar, Dipti, et al.. (2024). Synthesis and Evaluation of 2,5-Substituted Pyrimidines as Small-Molecule Gankyrin Binders. Future Medicinal Chemistry. 16(3). 239–251.

Wang, Xuechun, et al.. (2023). Surface-Modified Inhaled Microparticle-Encapsulated Celastrol for Enhanced Efficacy in Malignant Pleural Mesothelioma. International Journal of Molecular Sciences. 24(6). 5204–5204. 7 indexed citations

Vemana, Hari Priya, et al.. (2022). Repurposing an Antiepileptic Drug for the Treatment of Glioblastoma. Pharmaceutical Research. 39(11). 2871–2883. 8 indexed citations

Chilamakuri, Rameswari, et al.. (2021). BX-795 inhibits neuroblastoma growth and enhances sensitivity towards chemotherapy. Translational Oncology. 15(1). 101272–101272. 17 indexed citations

Kanabar, Dipti, et al.. (2021). Identification of novel gankyrin binding scaffolds by high throughput virtual screening. Bioorganic & Medicinal Chemistry Letters. 43. 128043–128043. 2 indexed citations

Shukla, Snehal K., Apoorva Sarode, Dipti Kanabar, et al.. (2021). Bioinspired particle engineering for non-invasive inhaled drug delivery to the lungs. Materials Science and Engineering C. 128. 112324–112324. 17 indexed citations

10.

Kanabar, Dipti, et al.. (2020). Optimizing the aryl-triazole of cjoc42 for enhanced gankyrin binding and anti-cancer activity. Bioorganic & Medicinal Chemistry Letters. 30(17). 127372–127372. 9 indexed citations

11.

Parvathaneni, Vineela, Nishant S. Kulkarni, Gautam Chauhan, et al.. (2020). Development of pharmaceutically scalable inhaled anti-cancer nanotherapy – Repurposing amodiaquine for non-small cell lung cancer (NSCLC). Materials Science and Engineering C. 115. 111139–111139. 37 indexed citations

12.

Wang, Xuechun, Vineela Parvathaneni, Snehal K. Shukla, et al.. (2020). Inhalable resveratrol-cyclodextrin complex loaded biodegradable nanoparticles for enhanced efficacy against non-small cell lung cancer. International Journal of Biological Macromolecules. 164. 638–650. 73 indexed citations

13.

Kulkarni, Nishant S., Vineela Parvathaneni, Snehal K. Shukla, et al.. (2019). Tyrosine kinase inhibitor conjugated quantum dots for non-small cell lung cancer (NSCLC) treatment. European Journal of Pharmaceutical Sciences. 133. 145–159. 51 indexed citations

14.

Li, Guangyuan, Anitha Sundararajan, Thiruvarangan Ramaraj, et al.. (2018). Histone Citrullination Represses MicroRNA Expression, Resulting in Increased Oncogene mRNAs in Somatolactotrope Cells. Molecular and Cellular Biology. 38(19). 23 indexed citations

15.

Harman, Rebecca M., et al.. (2018). BB-Cl-Amidine as a novel therapeutic for canine and feline mammary cancer via activation of the endoplasmic reticulum stress pathway. BMC Cancer. 18(1). 412–412. 21 indexed citations

16.

Qin, Hao, Xiaoqiu Liu, Fujun Li, et al.. (2017). PAD1 promotes epithelial-mesenchymal transition and metastasis in triple-negative breast cancer cells by regulating MEK1-ERK1/2-MMP2 signaling. Cancer Letters. 409. 30–41. 72 indexed citations

17.

Li, Guangyuan, Brittany R. Jenkins, Heather M. Rothfuss, et al.. (2016). Peptidylarginine Deiminase 3 (PAD3) Is Upregulated by Prolactin Stimulation of CID-9 Cells and Expressed in the Lactating Mouse Mammary Gland. PLoS ONE. 11(1). e0147503–e0147503. 10 indexed citations

18.

Zhang, Xiaoqian, Xiaoqiu Liu, Mei Zhang, et al.. (2016). Peptidylarginine deiminase 1-catalyzed histone citrullination is essential for early embryo development. Scientific Reports. 6(1). 38727–38727. 44 indexed citations

19.

Muth, Aaron, Vincent M. Crowley, Anuj Khandelwal, et al.. (2014). Development of radamide analogs as Grp94 inhibitors. Bioorganic & Medicinal Chemistry. 22(15). 4083–4098. 24 indexed citations

20.

Kurihara, Shin, Yumi Sakai, Hideyuki Suzuki, et al.. (2013). Putrescine Importer PlaP Contributes to Swarming Motility and Urothelial Cell Invasion in Proteus mirabilis. Journal of Biological Chemistry. 288(22). 15668–15676. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact